Profile | GDS5420 / 205025_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 578.12 | 70 |
GSM1296119 | B_lesional_pre-dose | 117.83 | 43 |
GSM1296076 | C_lesional_pre-dose | 122.56 | 46 |
GSM1296092 | D_lesional_pre-dose | 267.09 | 59 |
GSM1296103 | E_lesional_pre-dose | 452.94 | 66 |
GSM1296078 | F_lesional_pre-dose | 56.24 | 33 |
GSM1296107 | G_lesional_pre-dose | 145.12 | 46 |
GSM1296109 | H_lesional_pre-dose | 307.15 | 59 |
GSM1296080 | I_lesional_pre-dose | 603.51 | 71 |
GSM1296090 | J_lesional_pre-dose | 224.31 | 55 |
GSM1296074 | K_lesional_pre-dose | 145.68 | 50 |
GSM1296111 | L_lesional_pre-dose | 103.47 | 40 |
GSM1296099 | M_lesional_pre-dose | 266.89 | 57 |
GSM1296086 | O_lesional_pre-dose | 258.67 | 58 |
GSM1296117 | P_lesional_pre-dose | 131.78 | 44 |
GSM1296113 | Q_lesional_pre-dose | 216.73 | 52 |
GSM1296096 | R_lesional_pre-dose | 261.5 | 57 |
GSM1296105 | S_lesional_pre-dose | 355.55 | 61 |
GSM1296098 | T_lesional_pre-dose | 635.56 | 71 |
GSM1296101 | U_lesional_pre-dose | 592.5 | 70 |
GSM1296121 | V_lesional_pre-dose | 124.14 | 44 |
GSM1296088 | W_lesional_pre-dose | 325.29 | 61 |
GSM1296082 | X_lesional_pre-dose | 202.29 | 54 |
GSM1296115 | Y_lesional_pre-dose | 113.02 | 42 |
GSM1296084 | Z_lesional_pre-dose | 425.53 | 65 |
GSM1296072 | B_lesional_day8 | 177.5 | 49 |
GSM1296069 | L_lesional_day8 | 96.52 | 38 |
GSM1296071 | P_lesional_day8 | 195.06 | 50 |
GSM1296070 | Y_lesional_day8 | 132.48 | 43 |
GSM1296073 | V_lesional_day8 | 123.4 | 45 |
GSM1296034 | A_lesional_day15 | 1321.08 | 84 |
GSM1296041 | G_lesional_day15 | 133.64 | 45 |
GSM1296035 | R_lesional_day15 | 473.39 | 67 |
GSM1296038 | U_lesional_day15 | 210.87 | 53 |
GSM1296047 | B_lesional_day15 | 172.78 | 49 |
GSM1296039 | E_lesional_day15 | 164.59 | 50 |
GSM1296042 | H_lesional_day15 | 169.13 | 48 |
GSM1296043 | L_lesional_day15 | 128.95 | 43 |
GSM1296037 | M_lesional_day15 | 533.39 | 69 |
GSM1296046 | P_lesional_day15 | 169.17 | 48 |
GSM1296044 | Q_lesional_day15 | 240.74 | 54 |
GSM1296045 | Y_lesional_day15 | 173.2 | 48 |
GSM1296025 | C_lesional_day15 | 333.53 | 61 |
GSM1296033 | D_lesional_day15 | 438.91 | 65 |
GSM1296027 | I_lesional_day15 | 383.21 | 64 |
GSM1296032 | J_lesional_day15 | 618.17 | 71 |
GSM1296024 | K_lesional_day15 | 412.1 | 65 |
GSM1296031 | W_lesional_day15 | 435.8 | 65 |
GSM1296028 | X_lesional_day15 | 409.32 | 64 |
GSM1296029 | Z_lesional_day15 | 655.94 | 72 |
GSM1296026 | F_lesional_day15 | 182.96 | 52 |
GSM1296030 | O_lesional_day15 | 524.86 | 69 |
GSM1296040 | S_lesional_day15 | 469.67 | 66 |
GSM1296036 | T_lesional_day15 | 554.05 | 69 |
GSM1296048 | V_lesional_day15 | 157.45 | 48 |
GSM1296059 | A_lesional_day43 | 480.76 | 67 |
GSM1296066 | G_lesional_day43 | 171.42 | 49 |
GSM1296060 | R_lesional_day43 | 392.62 | 63 |
GSM1296063 | U_lesional_day43 | 217.28 | 54 |
GSM1296064 | E_lesional_day43 | 187.23 | 52 |
GSM1296067 | H_lesional_day43 | 310.81 | 58 |
GSM1296062 | M_lesional_day43 | 623.03 | 71 |
GSM1296068 | Q_lesional_day43 | 185.3 | 49 |
GSM1296050 | C_lesional_day43 | 109.24 | 43 |
GSM1296057 | D_lesional_day43 | 461.13 | 66 |
GSM1296052 | I_lesional_day43 | 449.4 | 66 |
GSM1296054 | J_lesional_day43 | 778.34 | 75 |
GSM1296049 | K_lesional_day43 | 327.35 | 61 |
GSM1296055 | W_lesional_day43 | 290 | 58 |
GSM1296053 | X_lesional_day43 | 677.38 | 72 |
GSM1296058 | Z_lesional_day43 | 544.26 | 69 |
GSM1296051 | F_lesional_day43 | 103.24 | 43 |
GSM1296056 | O_lesional_day43 | 308.95 | 60 |
GSM1296065 | S_lesional_day43 | 217.22 | 53 |
GSM1296061 | T_lesional_day43 | 669.45 | 72 |
GSM1296095 | A_non-lesional_pre-dose | 314.57 | 60 |
GSM1296120 | B_non-lesional_pre-dose | 150.57 | 46 |
GSM1296077 | C_non-lesional_pre-dose | 257.83 | 57 |
GSM1296093 | D_non-lesional_pre-dose | 686.26 | 73 |
GSM1296104 | E_non-lesional_pre-dose | 241.33 | 55 |
GSM1296079 | F_non-lesional_pre-dose | 220.04 | 55 |
GSM1296108 | G_non-lesional_pre-dose | 214.55 | 53 |
GSM1296110 | H_non-lesional_pre-dose | 184.61 | 49 |
GSM1296081 | I_non-lesional_pre-dose | 783.52 | 75 |
GSM1296091 | J_non-lesional_pre-dose | 352.67 | 62 |
GSM1296075 | K_non-lesional_pre-dose | 113.51 | 45 |
GSM1296112 | L_non-lesional_pre-dose | 212.28 | 51 |
GSM1296100 | M_non-lesional_pre-dose | 603.67 | 70 |
GSM1296087 | O_non-lesional_pre-dose | 297 | 60 |
GSM1296118 | P_non-lesional_pre-dose | 191.49 | 50 |
GSM1296114 | Q_non-lesional_pre-dose | 195.62 | 50 |
GSM1296097 | R_non-lesional_pre-dose | 268.4 | 57 |
GSM1296106 | S_non-lesional_pre-dose | 316.74 | 59 |
GSM1296102 | U_non-lesional_pre-dose | 637.03 | 71 |
GSM1296122 | V_non-lesional_pre-dose | 172.12 | 49 |
GSM1296089 | W_non-lesional_pre-dose | 449.67 | 65 |
GSM1296083 | X_non-lesional_pre-dose | 782.2 | 75 |
GSM1296116 | Y_non-lesional_pre-dose | 152.83 | 45 |
GSM1296085 | Z_non-lesional_pre-dose | 697.76 | 73 |